Instead of discovering a shortage at the point of care, that real-time usage and inventory trend allows the pharmacy teams to really see that risk earlier and adjust their sourcing, avoid those ...

In today’s Pharma Pulse, bipartisan lawmakers target PBM vertical integration, while pharma giants race to secure tariff-exempt pricing deals.

Bandy: The statistics that we found within the survey is that four inc five, which is equivalent to about 79%, are saying ...

1. Meijer Announces New Affordable Access to GLP-1 Medications. Meijer. February 10, 2026. Accessed February 11, 2026.

According to Reuters, some of the pharma companies that were not on the receiving end of President Trump’s May executive order (EO) 2 are interested in pursuing separate agreements in order to avoid ...

In today’s Pharma Pulse, the FDA issues a rare “Refusal-to-File" for Moderna’s influenza vaccine, while new research confirms GLP-1s act as potent tools against chronic inflammation.

Rising recalls, tighter FDA enforcement, global supply chain dependencies, and rapid technology shifts are reshaping ...

PC: Tecsys’ new survey shows that only 20% of healthcare leaders report having real-time visibility across pharmacy inventory and care settings. What specific visibility gaps are most common today, ...

View the Pharmaceutical Commerce February 2026 issue in an interactive format.

Hudicka also comments on practical steps can supply chain leaders take to build trust in AI-driven ecosystems without ...

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innov ...